Home › Funds › CAUSEWAY CAPITAL MANAGEMENT LLC › PHG
CAUSEWAY CAPITAL MANAGEMENT LLC position in PHG
KONINKLIJKE PHILIPS N V · Health Care
CAUSEWAY CAPITAL MANAGEMENT LLC reported holding 2,994,537 shares of PHG (KONINKLIJKE PHILIPS N V) in its Q3 2026 13F filing — a position valued at US$73.2M, representing 0.82% of its reported portfolio and ranking #17 among its reported holdings. CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed PHG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CAUSEWAY CAPITAL MANAGEMENT LLC's PHG position evolved
CAUSEWAY CAPITAL MANAGEMENT LLC first disclosed a stake in PHG in Q3 2023 at 1,092,037 shares (US$21.8M). The position peaked in Q2 2026 at 3,061,962 shares, worth US$83.3M. Across 13 filings, CAUSEWAY CAPITAL MANAGEMENT LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,994,537 shares valued at US$73.2M — a reduction of -67,425 shares quarter over quarter.. Notable position changes include a 28% increase in Q4 2023 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.09M | $21.78M | New |
| Q4 2023 | 1.39M | $32.49M | Add |
| Q1 2024 | 1.67M | $33.38M | Add |
| Q2 2024 | 1.29M | $32.49M | Reduce |
| Q3 2024 | 1.26M | $41.34M | Reduce |
| Q4 2024 | 1.57M | $39.67M | Add |
| Q1 2025 | 1.53M | $38.91M | Reduce |
| Q2 2025 | 1.85M | $44.39M | Add |
| Q3 2025 | 1.96M | $53.38M | Add |
| Q4 2025 | 2.20M | $59.54M | Add |
| Q1 2026 | 2.46M | $67.30M | Add |
| Q2 2026 | 3.06M | $83.25M | Add |
| Q3 2026 | 2.99M | $73.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PHG and 13F data
PHG (KONINKLIJKE PHILIPS N V) is a Health Care company. 17 other funds we track also report a position in PHG — the largest reported positions include Exor N.V. (US$4.54B), Mondrian Investment Partners LTD (US$192.6M), Causeway Capital Management (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHG
- Exor N.V. 185.93M sh · $4.54B · Q3 2026
- Mondrian Investment Partners LTD 7.89M sh · $192.65M · Q3 2026
- Causeway Capital Management 3.06M sh · $83.25M · Q2 2026
- FIDUCIARY MANAGEMENT INC /WI/ 3.29M sh · $80.45M · Q3 2026
- INVESTMENT MANAGEMENT ASSOCIATES INC /ADV 870.27K sh · $21.26M · Q3 2026
More on CAUSEWAY CAPITAL MANAGEMENT LLC
FAQ
How long has CAUSEWAY CAPITAL MANAGEMENT LLC held PHG?
CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed PHG holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CAUSEWAY CAPITAL MANAGEMENT LLC's current position in PHG?
As of Q3 2026, CAUSEWAY CAPITAL MANAGEMENT LLC holds 2.99M shares of PHG (KONINKLIJKE PHILIPS N V), valued at $73.16M, representing 0.82% of its reported portfolio and ranking #17.
Has CAUSEWAY CAPITAL MANAGEMENT LLC been buying or selling PHG?
In the latest 13F filing (Q3 2026), CAUSEWAY CAPITAL MANAGEMENT LLC reduced its position in PHG. The position peaked in Q2 2026 at 3.06M shares.
Which other funds hold PHG?
Other major institutional holders of PHG include Exor N.V., Mondrian Investment Partners LTD, Causeway Capital Management, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.